Results 201 to 210 of about 13,683 (246)

Long-term safety and efficacy of bimekizumab in axial spondyloarthritis: 2-year results from two phase 3 studies. [PDF]

Rheumatology (Oxford)
Baraliakos X, Deodhar A, van der Heijde D, Van den Bosch F, Magrey M, Maksymowych WP, Tomita T, Xu H, Massow U, Vaux T, Prajapati C, Manente M, Marten A, Gensler LS.   +13 more
europepmc   +1 more source

Injective Therapies for Managing Sacroiliac Joint Pain in Spondyloarthropathy: A Systematic Review and Meta-Analysis. [PDF]

J Clin Med
Cerasoli T, Filardo G, Favero A, Rinaldi VG, Di Maio L, Marcheggiani Muccioli GM, Zaffagnini S.   +6 more
europepmc   +1 more source

DEUS Enthesitis Index (DEI): a new tool integrating ultrasound and clinical examination for enthesitis assessment in spondyloarthritis. [PDF]

RMD Open
Di Matteo A, Di Donato S, Filippucci E.
europepmc   +1 more source

Metrnl/Meteorin-like/IL-41, a novel regulator of bone metabolism and disease activity in ankylosing spondylitis: based on multi-omics analysis. [PDF]

Front Immunol
Li Z, Sun T, Zhao M, Xia L, Shen H.
europepmc   +1 more source

Retrospective Analysis of Spinal Radiographs for the Presence of Lumbosacral Transitional Vertebra in Patients with Axial Spondyloarthritis. [PDF]

Arch Rheumatol
Kasap Z, Er E.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Comparison of ASDAS and BASDAI as a measure of disease activity in axial psoriatic arthritis

Clinical Rheumatology, 2015
The aim of this study was to compare the discriminative ability of Ankylosing Spondylitis Disease Activity Score (ASDAS) with Bath Ankylosing Spondylitis Activity Disease Activity Index (BASDAI) and other clinical disease activity parameters in patients with axial psoriatic arthritis (axPsA).
Gamze Kıl, Erkan Kilic, Kemal Nas
exaly   +6 more sources

Disease activity assessment in ankylosing spondylitis in a Chinese cohort: BASDAI or ASDAS?

Clinical Rheumatology, 2014
Recently, the Ankylosing Spondylitis Disease Activity Score (ASDAS), a new index, has been shown to be validated and highly discriminatory in assessing ankylosing spondylitis (AS) disease activity. This study is to evaluate the performance of ASDAS in a local Chinese cohort of AS in a cross-sectional setting and to compare it with the existing ...
Mo Yin Mok, Ho Yin Chung, Chak Sing Lau
exaly   +7 more sources

Clinical utility of the ASDAS index in comparison with BASDAI in patients with ankylosing spondylitis (Axis Study)

Rheumatology International, 2017
The objective of the study was to study the clinical utility of the Ankylosing Spondylitis Disease Activity Score (ASDAS) for the assessment of disease activity in ankylosing spondylitis (AS) patients, compared to the Bath Ankylosing Spondylitis Activity Index (BASDAI).
Eduardo Collantes-estévez
exaly   +5 more sources

Evaluation of spondylarthritis activity by patients and physicians: ASDAS, BASDAI, PASS, and flares in 200 patients

Joint Bone Spine, 2013
In patients with spondyloarthritis, to determine Ankylosing Spondylitis Disease Activity Score (ASDAS) cutoffs matching the patient-acceptable symptom state (PASS) and patient-reported levels of disease activity, to assess associations between disease activity levels and presence of depression, and to identify ASDAS and Bath Ankylosing Spondylitis ...
Daniel Wendling
exaly   +5 more sources